Skip to main content
. Author manuscript; available in PMC: 2020 Jan 15.
Published in final edited form as: Int J Cancer. 2019 Jul 1;146(2):566–576. doi: 10.1002/ijc.32510

Figure 1.

Figure 1

Frequent alterations among blood-derived ctDNA and tissue biopsy (n = 433). Percentage denotes percent of patients with an alteration. Most common alterations in both ctDNA and tissue in 433 patients with diverse cancers who had both ctDNA and tissue biopsy are shown. VUS alterations were excluded. If two different samples were collected for a patient, only the tissue and blood samples closest together timewise were counted.